Patent application number | Description | Published |
20090247750 | PROCESS FOR PREPARING NUCLEOSIDE ANALOGS - The invention provides an improved method for preparing a compound of formula 2: | 10-01-2009 |
20100015094 | ANTIVIRAL NUCLEOSIDE ANALOGS - The invention provides compounds of Formula (I), as described herein, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates that are useful for preparing the compounds. The compounds of Formula (I) are useful as anti-viral agents and/or as anti-cancer agents. | 01-21-2010 |
20110144321 | SYNTHETIC INTERMEDIATES AND PROCESSES - The invention provides novel synthetic intermediates and processes that can be used to prepare compounds of formula (I), wherein R | 06-16-2011 |
20110165183 | PIPERIDINE DERIVATIVES AS JAK3 INHIBITORS - The invention provides a compound of formula (I): wherein W is a bicyclic heteroaromatic group; or a salt thereof. The compounds and salts thereof have beneficial therapeutic properties (e.g. immunosuppressant properties). | 07-07-2011 |
20120309773 | HETEROCYCLIC COMPOUNDS AS JANUS KINASE INHIBITORS - The invention provides compounds of formula I: | 12-06-2012 |
20130071415 | Heterocyclic Compounds as Janus Kinase Inhibitors - The invention provides compounds of formula I: | 03-21-2013 |
20130331404 | Methods and Compositions for Inhibition of Polymerase - The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects. The methods comprise administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, or a composition comprising a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier. The composition or method may optionally comprise one or more additional anti-viral agents. | 12-12-2013 |
20150051230 | Methods and Compositions for Inhibition of Polymerase - The present invention is directed to methods and compositions for inhibition of viral nucleic acid polymerases, such as RNA and DNA polymerases, and methods and compositions that are useful for treating viral infections in subjects. The methods comprise administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, or a composition comprising a compound of formula I, or a pharmaceutically acceptable salt or hydrate thereof, and a pharmaceutically acceptable carrier. The composition or method may optionally comprise one or more additional anti-viral agents. | 02-19-2015 |